SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-22-053567
Filing Date
2022-10-13
Accepted
2022-10-13 16:15:50
Documents
2
Period of Report
2022-10-11

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 8317
2 EX-24 DOCUMENT attachment1.htm EX-24 4247
  Complete submission text file 0001209191-22-053567.txt   14010
Mailing Address C/O SYROS PHARMACEUTICALS, INC. 620 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address
Quirk Gerald E (Reporting) CIK: 0001479603 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37813 | Film No.: 221309227

Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Issuer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations